LOOMIS SAYLES & CO L P - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$81,314
-32.6%
2,129,204
+0.4%
0.14%
-41.7%
Q4 2022$120,660
-99.9%
2,120,571
-1.3%
0.24%
+40.7%
Q3 2022$84,943,000
-11.1%
2,148,273
-1.1%
0.17%
-2.8%
Q2 2022$95,590,000
+9.7%
2,172,478
-0.6%
0.18%
+52.6%
Q1 2022$87,149,000
+12.4%
2,185,274
+13.4%
0.12%
+23.4%
Q4 2021$77,514,000
-3.3%
1,927,738
-2.1%
0.09%
-5.1%
Q3 2021$80,141,000
-10.6%
1,970,055
-0.3%
0.10%
-9.2%
Q2 2021$89,693,000
+8.6%
1,975,194
-0.3%
0.11%
+1.9%
Q1 2021$82,599,000
-2.6%
1,981,256
-0.2%
0.11%
-4.5%
Q4 2020$84,781,000
+123.0%
1,985,026
+37.2%
0.11%
+103.6%
Q3 2020$38,024,000
-0.1%
1,446,855
+1.9%
0.06%
-9.8%
Q2 2020$38,052,000
+63.2%
1,419,336
+9.5%
0.06%
+27.1%
Q1 2020$23,315,000
+2.1%
1,296,003
+0.6%
0.05%
+23.1%
Q4 2019$22,835,000
+13.9%
1,287,945
-0.3%
0.04%0.0%
Q3 2019$20,041,0001,292,1630.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders